MDT

89.67

-0.33%↓

VEEV

282.88

+2.55%↑

A

120.56

-2.22%↓

WBA

11.48

-0.26%↓

HQY

96.75

+2.44%↑

MDT

89.67

-0.33%↓

VEEV

282.88

+2.55%↑

A

120.56

-2.22%↓

WBA

11.48

-0.26%↓

HQY

96.75

+2.44%↑

MDT

89.67

-0.33%↓

VEEV

282.88

+2.55%↑

A

120.56

-2.22%↓

WBA

11.48

-0.26%↓

HQY

96.75

+2.44%↑

MDT

89.67

-0.33%↓

VEEV

282.88

+2.55%↑

A

120.56

-2.22%↓

WBA

11.48

-0.26%↓

HQY

96.75

+2.44%↑

MDT

89.67

-0.33%↓

VEEV

282.88

+2.55%↑

A

120.56

-2.22%↓

WBA

11.48

-0.26%↓

HQY

96.75

+2.44%↑

Search

Altimmune Inc

Abierto

4.18 0.97

Resumen

Variación precio

24h

Actual

Mínimo

4.07

Máximo

4.28

Métricas clave

By Trading Economics

Ingresos

3.6M

-20M

Ventas

5K

Margen de beneficios

-391,500

Empleados

59

EBITDA

2.9M

-20M

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 Meses

+356.28% upside

Dividendos

By Dow Jones

Próximas Ganancias

7 ago 2025

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

-104M

359M

Apertura anterior

3.21

Cierre anterior

4.18

Puntuación técnica

By Trading Central

Confianza

Bullish Evidence

Altimmune Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

11 jul 2025, 22:19 UTC

Adquisiciones, fusiones, absorciones

FCC Approves U.S. Cellular Sale to T-Mobile

11 jul 2025, 17:28 UTC

Principales Movimientos del Mercado

SharpLink Gaming Gains on Ethereum Purchase

11 jul 2025, 16:57 UTC

Ganancias

BASF Cuts Outlook on Global Economy Uncertainty

13 jul 2025, 23:54 UTC

Charlas de Mercado

Oil Edges Higher Amid Supply Disruption Worries -- Market Talk

13 jul 2025, 23:49 UTC

Charlas de Mercado

Nikkei May Fall Amid U.S. Tariff Uncertainty -- Market Talk

13 jul 2025, 23:49 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

13 jul 2025, 23:40 UTC

Charlas de Mercado

Market Talk Roundup: Latest on U.S. Politics

13 jul 2025, 23:40 UTC

Charlas de Mercado

Gold Advances Amid Rising Trade Tensions -- Market Talk

13 jul 2025, 23:39 UTC

Charlas de Mercado

China's Growth Momentum Likely Slowed in 2Q -- Market Talk

13 jul 2025, 23:16 UTC

Ganancias

China Shenhua Energy 1H 2024 Net Was CNY32.8B>1088.HK

13 jul 2025, 23:16 UTC

Ganancias

China Shenhua Energy: Drop in Coal Prices Weighed on Results >1088.HK

13 jul 2025, 23:16 UTC

Ganancias

China Shenhua Energy Sees 1H Net CNY25.6B-Net CNY27.6B >1088.HK

13 jul 2025, 23:13 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

13 jul 2025, 23:13 UTC

Charlas de Mercado

Ryman Healthcare Could Be Turning a Corner -- Market Talk

13 jul 2025, 11:00 UTC

Adquisiciones, fusiones, absorciones

The Private-Equity Maneuver Allowing More Investors to Cash Out -- WSJ

12 jul 2025, 02:24 UTC

Adquisiciones, fusiones, absorciones

Google to Pay $2.4 Billion in Deal to License Tech of Coding Startup, Hire CEO -- Update

12 jul 2025, 02:05 UTC

Adquisiciones, fusiones, absorciones

Google to Pay $2.4 Billion in Deal to License Tech of Coding Startup, Hire CEO -- WSJ

12 jul 2025, 02:05 UTC

Adquisiciones, fusiones, absorciones

Google to Hire Windsurf CEO and Other Employees, Company Says -- WSJ

12 jul 2025, 02:05 UTC

Adquisiciones, fusiones, absorciones

Google to Pay About $2.4 Billion in Deal to License Tech of AI Coding Startup, Sources Say -- WSJ

11 jul 2025, 21:45 UTC

Charlas de Mercado

Fitch Affirms Germany's Rating, Sees Deficit, Debt Rising -- Market Talk

11 jul 2025, 19:46 UTC

Adquisiciones, fusiones, absorciones

Kraft Heinz Might Split Up, Report Says. What Investors Need to Know. -- Barrons.com

11 jul 2025, 19:45 UTC

Charlas de Mercado

Crude Futures Post Back-to-Back Weekly Gains -- Market Talk

11 jul 2025, 19:05 UTC

Charlas de Mercado

U.S. Natural Gas Futures Post Third Straight Weekly Loss -- Market Talk

11 jul 2025, 18:18 UTC

Charlas de Mercado

Canada Officials Tight-Lipped on Next Steps in Trump Trade Talks -- Market Talk

11 jul 2025, 17:35 UTC

Charlas de Mercado

Canada Should Target Lower Sectoral Tariffs, Import Quotas in US Trade Talks -- Market Talk

11 jul 2025, 17:26 UTC

Charlas de Mercado

U.S. Oil Rig Count Down by 1 to 424 -- Market Talk

11 jul 2025, 16:53 UTC

Charlas de Mercado

Crude Futures Add to Early Gains -- Market Talk

11 jul 2025, 16:42 UTC

Ganancias

BASF Cuts Outlook on Global Economic Uncertainty

11 jul 2025, 16:08 UTC

Charlas de Mercado

Rise in Canadian Staycations May Help Explain Labor Market Strength -- Market Talk

11 jul 2025, 16:05 UTC

Ganancias

BASF Will Publish Half-Year Results on July 30

Comparación entre iguales

Cambio de precio

Altimmune Inc previsión

Precio Objetivo

By TipRanks

356.28% repunte

Estimación a 12 Meses

Media 18.89 USD  356.28%

Máximo 28 USD

Mínimo 1 USD

De acuerdo con 10 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Altimmune Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

10 ratings

8

Comprar

1

Mantener

1

Vender

Puntuación técnica

By Trading Central

5.365 / 6.0486Soporte y Resistencia

Corto Plazo

Bullish Evidence

Medio plazo

Weak Bullish Evidence

Largo Plazo

Bearish Evidence

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Altimmune Inc

Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide, a GLP-1/glucagon dual receptor agonist that is in Phase 2 trial for the treatment of obesity and metabolic dysfunction-associated steatohepatitis. It is also developing HepTcell, an immunotherapeutic product candidate, which is in Phase 2 clinical trial for patients chronically infected with the hepatitis B virus. The company was formerly known as Vaxin Inc. and changed its name to Altimmune, Inc. in September 2015. Altimmune, Inc. was founded in 1997 is headquartered in Gaithersburg, Maryland.